HCW Biologics Inc.
HCW Biologics Inc. (HCWB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HCWB · as of Jun 8, 2026
Key Statistics
Explore HCW Biologics Inc. Data
hcwb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
hcwb competitorsHCWB
ACXP
ADIL
APRE
APVO
BCDAStock Performance
Full HistoryAbout HCW Biologics Inc.
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused…
what is hcw biologics inc. · hcwb stock overview · hcw biologics inc. company profile · who is hcw biologics inc. ceo · hcwb NASDAQ · hcw biologics inc. headquarters · hcw biologics inc. business segments
About Stock Overview & Key Data
HCW Biologics Inc. (HCWB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 20, 2021. As of the latest trading session, HCWB stock price is $1.45, with a market capitalization of $3.0M. The stock has returned -74.01% over the past 12 months and +49.39% year-to-date.
According to 3 Wall Street analysts, the consensus rating for HCW Biologics Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, HCW Biologics Inc. reported revenue of $54232.00 and net income of -$8.0M. For detailed data — including HCW Biologics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HCW Biologics Inc. (HCWB) stock price is $1.45. The stock is traded on NASDAQ under the ticker symbol HCWB. The 52-week range is $0.25 – $7.35.